Aptevo Therapeutics (APVO) Tops Q1 EPS by 161c

Aptevo Therapeutics (NASDAQ: APVO) reported Q1 EPS of $0.26, $1.61 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• Eversource completes $2.4B sale of Aquarion Water Company